Novel Bio announces collaborative partnership with Culture Biosciences to scale-up NBx Platform™ for plasmid DNA production
Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA for use in genetic medicines, announced today that they have formed a partnership with Culture Biosciences to accelerate the development of scalable fermentation processes for their proprietary NBx Platform™ for plasmid DNA production.
- Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA for use in genetic medicines, announced today that they have formed a partnership with Culture Biosciences to accelerate the development of scalable fermentation processes for their proprietary NBx Platform™ for plasmid DNA production.
- View the full release here: https://www.businesswire.com/news/home/20240305254120/en/
Since the 1970s, plasmid DNA has been produced using the simple bacterium E. coli. - For the past 2 years Novel Bio has been developing a new microbe to solve key manufacturing challenges.
- “Instead, we decided to partner with Culture Biosciences to access their amazing team and their custom-built, cloud-connected bioreactors.